tradingkey.logo

Koninklijke Philips NV

PHG
27.320USD
+0.050+0.18%
Close 10/31, 16:00ETQuotes delayed by 15 min
25.97BMarket Cap
134.26P/E TTM

Koninklijke Philips NV

27.320
+0.050+0.18%

More Details of Koninklijke Philips NV Company

Koninklijke Philips NV is a Netherlands-based health technology company. The Company's segments include Personal Health businesses, Diagnosis & Treatment businesses, Connected Care businesses and Other. The Personal Health businesses segment is engaged in the health continuum, delivering integrated, connected solutions that support healthier lifestyles and those living with chronic disease as well as oral healthcare and mother and child care support. The Diagnosis & Treatment businesses segment delivers precision medicine and treatment, and therapy. The Connected Care businesses segment provides consumers, care givers and clinicians with digital solutions that facilitate care by enabling precision medicine and population health management. The Other segment comprises such items, as innovation, emerging businesses, royalties, among others.

Koninklijke Philips NV Info

Ticker SymbolPHG
Company nameKoninklijke Philips NV
IPO dateSep 18, 2009
CEOMr. Roy Jakobs
Number of employees67823
Security typeOrdinary Share
Fiscal year-endSep 18
AddressHigh Tech Campus 5
CityEINDHOVEN
Stock exchangeThe Stock Exchange of Thailand
CountryNetherlands
Postal code5656 AE
Phone31205977777
Websitehttps://www.philips.com/
Ticker SymbolPHG
IPO dateSep 18, 2009
CEOMr. Roy Jakobs

Company Executives of Koninklijke Philips NV

Name
Name/Position
Position
Shareholding
Change
Mr. Steve C. De Baca
Mr. Steve C. De Baca
Executive Vice President, Chief Patient Safety and Quality Officer
Executive Vice President, Chief Patient Safety and Quality Officer
--
--
Mr. Benoit Ribadeau-Dumas
Mr. Benoit Ribadeau-Dumas
Member of the Supervisory Board
Member of the Supervisory Board
--
--
Ms. Jie Xue
Ms. Jie Xue
Executive Vice President, Chief Business Leader Precision Diagnosis
Executive Vice President, Chief Business Leader Precision Diagnosis
--
--
Ms. M. Elizabeth (Liz) Doherty
Ms. M. Elizabeth (Liz) Doherty
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mr. Bert Van Meurs
Mr. Bert Van Meurs
Executive Vice President, Chief Business Leader - Image Guided Therapy
Executive Vice President, Chief Business Leader - Image Guided Therapy
--
--
Ms. Julia Strandberg
Ms. Julia Strandberg
Executive Vice President, Chief Business Leader Connected Care
Executive Vice President, Chief Business Leader Connected Care
--
--
Ms. Ozlem Duzen Fidanci
Ms. Ozlem Duzen Fidanci
Executive Vice President, Chief of International Region and Leader Growth Region
Executive Vice President, Chief of International Region and Leader Growth Region
--
--
Ms. Liu Ling
Ms. Liu Ling
Executive Vice President, Chief Region Leader of Philips Greater China
Executive Vice President, Chief Region Leader of Philips Greater China
--
--
Mr. A. Marc Harrison
Mr. A. Marc Harrison
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Ms. Herna Verhagen
Ms. Herna Verhagen
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Steve C. De Baca
Mr. Steve C. De Baca
Executive Vice President, Chief Patient Safety and Quality Officer
Executive Vice President, Chief Patient Safety and Quality Officer
--
--
Mr. Benoit Ribadeau-Dumas
Mr. Benoit Ribadeau-Dumas
Member of the Supervisory Board
Member of the Supervisory Board
--
--
Ms. Jie Xue
Ms. Jie Xue
Executive Vice President, Chief Business Leader Precision Diagnosis
Executive Vice President, Chief Business Leader Precision Diagnosis
--
--
Ms. M. Elizabeth (Liz) Doherty
Ms. M. Elizabeth (Liz) Doherty
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mr. Bert Van Meurs
Mr. Bert Van Meurs
Executive Vice President, Chief Business Leader - Image Guided Therapy
Executive Vice President, Chief Business Leader - Image Guided Therapy
--
--
Ms. Julia Strandberg
Ms. Julia Strandberg
Executive Vice President, Chief Business Leader Connected Care
Executive Vice President, Chief Business Leader Connected Care
--
--

Revenue Breakdown

Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
No Data
By RegionUSD
Name
Revenue
Proportion
North America
2.12B
43.04%
Growth geographies
1.33B
27.16%
Western Europe
1.05B
21.35%
Other Mature geographies
415.83M
8.46%
By Business
By Region
No Data

Shareholding Stats

Updated: Sat, Oct 11
Updated: Sat, Oct 11
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Fiduciary Management, Inc.
0.79%
Mondrian Investment Partners Ltd.
0.75%
Dimensional Fund Advisors, L.P.
0.47%
Fidelity Management & Research Company LLC
0.26%
Causeway Capital Management LLC
0.19%
Other
97.54%
Shareholders
Shareholders
Proportion
Fiduciary Management, Inc.
0.79%
Mondrian Investment Partners Ltd.
0.75%
Dimensional Fund Advisors, L.P.
0.47%
Fidelity Management & Research Company LLC
0.26%
Causeway Capital Management LLC
0.19%
Other
97.54%
Shareholder Types
Shareholders
Proportion
Investment Advisor
4.04%
Investment Advisor/Hedge Fund
0.90%
Research Firm
0.23%
Hedge Fund
0.11%
Family Office
0.05%
Bank and Trust
0.05%
Family Office
0.04%
Family Office
0.04%
Other
94.53%

Institutional Shareholding

Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
564
50.74M
5.34%
-17.81M
2025Q2
560
58.95M
6.20%
-8.73M
2025Q1
579
60.52M
6.54%
-8.45M
2024Q4
583
60.06M
6.49%
-29.02M
2024Q3
590
63.64M
6.83%
-28.01M
2024Q2
594
65.28M
6.99%
-29.22M
2024Q1
610
73.19M
7.82%
-21.31M
2023Q4
642
73.00M
7.79%
-18.85M
2023Q3
666
68.56M
7.24%
-21.16M
2023Q2
676
66.71M
7.01%
-36.31M
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
Fiduciary Management, Inc.
7.46M
0.79%
-52.29K
-0.70%
Jun 30, 2025
Mondrian Investment Partners Ltd.
7.11M
0.75%
-23.58K
-0.33%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
4.50M
0.47%
+100.26K
+2.28%
Jun 30, 2025
Fidelity Management & Research Company LLC
2.42M
0.26%
-2.21M
-47.72%
Jun 30, 2025
Causeway Capital Management LLC
1.85M
0.19%
+319.18K
+20.84%
Jun 30, 2025
Parametric Portfolio Associates LLC
1.72M
0.18%
-14.59K
-0.84%
Jun 30, 2025
Brandes Investment Partners, L.P.
1.53M
0.16%
+538.72K
+54.29%
Jun 30, 2025
Northern Trust Global Investments
1.52M
0.16%
+139.35K
+10.12%
Jun 30, 2025
Envestnet Asset Management, Inc.
1.35M
0.14%
+32.66K
+2.48%
Jun 30, 2025
Connor, Clark & Lunn Investment Management Ltd.
1.32M
0.14%
-432.38K
-24.62%
Jun 30, 2025
View more

Related ETFs

Updated: Mon, Oct 6
Updated: Mon, Oct 6
Name
Proportion
Langar Global HealthTech ETF
4.4%
Brandes International ETF
2.06%
Brandes US Small-Mid Cap Value ETF
1.17%
ActivePassive International Equity ETF
0.24%
DFA Dimensional Intl Sustainability Core 1 ETF
0.15%
SPDR S&P Kensho New Economies Composite ETF
0.12%
DFA Dimensional International Core Equity 2 ETF
0.09%
Avantis Responsible International Equity ETF
0.08%
Avantis International Equity ETF
0.08%
Dimensional International Core Equity Market ETF
0.07%
View more
Langar Global HealthTech ETF
Proportion4.4%
Brandes International ETF
Proportion2.06%
Brandes US Small-Mid Cap Value ETF
Proportion1.17%
ActivePassive International Equity ETF
Proportion0.24%
DFA Dimensional Intl Sustainability Core 1 ETF
Proportion0.15%
SPDR S&P Kensho New Economies Composite ETF
Proportion0.12%
DFA Dimensional International Core Equity 2 ETF
Proportion0.09%
Avantis Responsible International Equity ETF
Proportion0.08%
Avantis International Equity ETF
Proportion0.08%
Dimensional International Core Equity Market ETF
Proportion0.07%

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Split

Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
KeyAI